endotheli
cell
creat
physic
barrier
lumin
surfac
blood
lymphat
vessel
barrier
must
travers
bloodborn
pathogen
immun
cell
traffick
tissu
bloodstream
mani
herpesvirus
requir
system
spread
persist
within
host
therefor
must
cross
endotheli
cell
barrier
date
herpesvirus
implic
potenti
initi
arteri
injuri
endotheli
dysfunct
local
inflamm
possibl
contribut
pathogenesi
atherosclerosi
human
cytomegaloviru
hcmv
betaherpesviru
infect
endotheli
cell
vivo
studi
shown
infect
endotheli
cell
play
role
hcmv
dissemin
pathogenesi
endotheli
cell
exhibit
region
special
gene
express
morpholog
depend
local
physiolog
demand
respect
organ
tissu
light
divers
surpris
endotheli
cell
differ
tissu
differ
suscept
hcmv
infect
kaposi
sarcomaassoci
herpesviru
kshv
human
gammaherpesviru
also
infect
endotheli
cell
vivo
importantli
kshv
caus
agent
endotheli
cell
neoplasm
kaposi
sarcoma
ks
murin
gammaherpesviru
detect
aortic
endothelium
infect
apo
defici
mice
well
lumin
surfac
explant
aorta
infect
vitro
relationship
gammaherpesvirus
endotheli
cell
note
role
endotheli
cell
chronic
gammaherpesviru
infect
pathogenesi
illdefin
gammaherpesvirus
lymphotrop
famili
virus
associ
broad
spectrum
malign
lymphoprolif
diseas
oncogen
virus
persist
life
host
establish
maintain
latent
infect
gammaherpesvirus
extrem
hostspecif
studi
human
virus
epsteinbarr
viru
ebv
kshv
nonhuman
system
mimic
natur
infect
natur
pathogen
wild
murid
rodent
therefor
provid
valuabl
small
anim
model
gammaherpesviru
infect
viru
import
biolog
genet
similar
human
gammaherpesvirus
result
varieti
patholog
defin
mous
model
primari
infect
character
viru
replic
lung
epitheli
cell
establish
latenc
b
cell
dendrit
cell
macrophag
persist
infect
also
occur
lung
epitheli
cell
role
endotheli
cell
infect
explor
date
cellular
level
gammaherpesviru
infect
encompass
two
broadli
defin
outcom
product
lytic
replic
nonproduct
latent
infect
lytic
replic
viral
dna
amplifi
host
cell
machineri
util
product
viral
progeni
viral
gene
activ
transcrib
translat
contribut
new
viru
product
ultim
cell
lyse
infecti
viru
releas
light
fact
process
occur
quickli
hour
vitro
understand
virushost
interact
primari
infect
quit
limit
latenc
viral
dna
amplifi
instead
maintain
nuclear
episom
latent
infect
cell
littl
viral
gene
transcript
occur
latent
infect
cell
remain
intact
produc
new
infecti
viru
furthermor
thought
longliv
latent
cell
may
serv
major
mechan
gammaherpesvirus
promot
lifelong
infect
host
character
infect
endotheli
cell
date
vitro
infect
cell
support
signific
viral
replic
result
complet
cell
lysi
data
shown
van
dyk
infect
primari
endotheli
cell
endotheli
cell
line
demonstr
produc
compar
amount
viru
fibroblast
howev
wherea
fibroblast
mostli
lyse
hour
postinfect
signific
percentag
infect
endotheli
cell
remain
intact
analysi
endotheli
cell
line
reveal
intact
cell
activ
infect
undergo
lytic
transcript
program
continu
prolifer
prolong
time
infect
alter
morpholog
cellsurfac
protein
express
compar
uninfect
endotheli
cell
continu
releas
infecti
virion
far
day
postinfect
absenc
viral
cyclin
endotheli
cell
viabil
significantli
decreas
infect
indic
activ
viral
process
respons
promot
outcom
infect
endotheli
cell
major
signific
also
provid
evid
endotheli
cell
infect
primari
cell
vivo
immunedefici
mice
data
demonstr
endotheli
cell
support
persist
product
gammaherpesviru
infect
outcom
previous
report
gammaherpesvirus
togeth
data
indic
potenti
endotheli
cell
critic
cell
type
pathogenesi
open
new
avenu
research
herpesviru
manipul
endotheli
cell
biolog
endotheli
cell
heterogen
natur
express
uniqu
surfac
antigen
differ
suscept
respons
infect
variou
pathogen
light
divers
investig
endotheli
cell
line
variou
anatom
locat
balbc
mice
abil
support
replic
analyz
outcom
infect
endotheli
cell
line
lung
brain
capillari
lymph
node
svec
singlestep
multistep
growth
assay
singl
step
growth
proceed
kinet
similar
previous
publish
infect
fibroblast
cell
line
nih
cell
three
endotheli
cell
line
analyz
fig
top
panel
though
equival
number
cell
plate
per
well
differ
amongst
endotheli
cell
line
titer
time
zero
surpris
given
cell
line
grow
vari
rate
vari
densiti
comparison
viral
titer
hour
reveal
three
endotheli
cell
line
produc
titer
compar
achiev
fibroblast
cell
addit
multistep
growth
endotheli
cell
similar
growth
fibroblast
fig
bottom
panel
data
demonstr
capabl
replic
endotheli
cell
infect
vitro
use
gfplabel
viru
next
sought
determin
percentag
infect
endotheli
cell
compar
percentag
infect
fibroblast
follow
infect
endotheli
cell
fibroblast
cell
analyz
express
gfp
genom
flow
cytometri
hour
postinfect
major
endotheli
cell
fibroblast
express
gfp
fig
data
indic
like
fibroblast
endotheli
cell
uniformli
infect
support
lytic
transcript
program
uninfect
endotheli
cell
fibroblast
grew
adher
monolay
fig
top
panel
howev
infect
endotheli
cell
cultur
observ
popul
intact
phasebright
nonadher
cell
earli
hour
postinfect
wherea
cellular
debri
remain
infect
fibroblast
cultur
data
shown
six
day
postinfect
collect
nonadher
cell
cellular
remain
centrifug
wash
resuspend
materi
complet
media
cultur
analysi
cell
harvest
infect
endotheli
cultur
appear
individu
intact
cell
suspend
cultur
wherea
materi
harvest
infect
fibroblast
cultur
appear
clump
cellular
debri
fig
bottom
panel
prior
centrifug
measur
cell
viabil
trypan
blue
exclus
infect
fibroblast
remain
viabl
nonadher
cell
six
day
postinfect
fig
howev
signific
proport
endotheli
cell
remain
viabl
nonadher
cell
six
day
postinfect
endotheli
cell
treat
nontox
dose
phosphonoacet
acid
paa
inhibitor
viral
dna
replic
late
gene
synthesi
cell
remain
adher
significantli
fewer
detach
viabl
cell
fig
paa
alon
effect
viabil
adher
phenotyp
uninfect
cell
cultur
data
shown
data
reveal
popul
endotheli
cell
becam
nonadher
remain
viabl
six
day
postinfect
wherea
fibroblast
destroy
infect
addit
outcom
infect
endotheli
cell
influenc
late
viral
gene
express
cell
remain
adher
presenc
paa
next
determin
statu
viru
replic
viabl
nonadher
cell
cell
collect
six
day
postinfect
analyz
flow
cytometri
express
glycoprotein
express
lytic
transcript
program
surfac
infect
cell
cell
viabil
also
determin
use
propidium
iodid
pi
cell
imperm
dye
exclud
intact
cell
membran
experi
also
includ
cell
line
mous
b
cell
lymphoma
line
harbor
latent
therefor
neg
surfac
express
major
endotheli
cell
fibroblast
posit
surfac
express
fig
fibroblast
mostli
pi
posit
endotheli
cell
exclud
pi
data
indic
endotheli
cell
remain
viabl
six
day
postinfect
undergo
lytic
transcript
program
latent
uninfect
day
postinfect
determin
viabil
cell
collect
cultur
six
day
postinfect
pi
stain
cell
six
day
cultur
reveal
sem
cell
pi
neg
thu
viabl
pi
stain
postinfect
fibroblast
treat
parallel
infect
endotheli
cell
reveal
sem
cell
harvest
remain
intact
contrast
pi
stain
postinfect
endotheli
cell
reveal
sem
cell
harvest
intact
viabl
fig
analysi
viral
replic
program
endotheli
cell
day
postinfect
reveal
major
cell
continu
express
fig
therefor
infect
endotheli
cell
result
popul
cell
escap
lysi
remain
intact
far
day
postinfect
undergo
lytic
transcript
program
observ
viabil
endotheli
cell
infect
could
result
escap
infect
latent
infect
cell
determin
infect
statu
intact
endotheli
cell
perform
rtpcr
analysi
viral
gene
transcript
gene
transcript
synthes
lytic
latent
infect
polymeras
iii
pol
iii
transcript
encod
left
end
viral
genom
latent
infect
cell
contain
pol
transcript
fig
detect
transcript
fibroblast
hour
postinfect
well
cellular
debri
harvest
six
day
postinfect
cellular
transcript
detect
infect
cell
hour
postinfect
rna
could
detect
infect
debri
day
postinfect
wherea
recov
rna
infect
cell
far
day
postinfect
pol
transcript
detect
infect
cell
hour
postinfect
intact
cultur
cell
six
day
postinfect
detect
rna
infect
cell
hour
postinfect
six
day
postinfect
howev
detect
anoth
cellular
mrna
transcript
cyclophilin
six
day
postinfect
fibroblast
cell
fig
compar
detect
cellular
rrna
transcript
observ
condit
gradual
loss
cellular
transcript
viabl
cell
surpris
given
document
vari
significantli
set
viru
infect
select
degrad
certain
mrna
frequent
occur
viru
infect
analysi
viral
gene
transcript
indic
endotheli
cell
remain
intact
infect
contain
viral
gene
transcript
far
day
postinfect
determin
whether
intact
infect
endotheli
cell
undergo
activ
viral
replic
analyz
infect
cell
express
earli
late
lytic
replicationassoci
gb
predict
fibroblast
support
lytic
replic
express
gb
fig
contrast
b
cell
contain
latent
express
either
gb
intact
infect
endotheli
cell
express
gb
earli
hour
also
six
day
postinfect
faster
migrat
gbspecif
band
also
detect
six
day
postinfect
may
indic
differenti
glycosyl
degrad
addit
infect
endotheli
cell
posit
surfac
protein
express
day
postinfect
fig
analysi
lytic
protein
express
indic
endotheli
cell
remain
intact
infect
express
earli
late
lytic
protein
indic
infect
endotheli
cell
still
contain
viru
cell
also
express
viral
protein
indic
activ
viral
replic
latenc
test
statu
viral
replic
endotheli
cell
infect
endotheli
cell
collect
intact
nonadher
cell
six
day
postinfect
gfp
express
driven
cmv
immedi
earli
promot
demonstr
express
lytic
infect
time
harvest
cell
uniformli
express
gfp
fig
histogram
continu
day
postinfect
fig
micrograph
therefor
nonadher
endotheli
cell
remain
intact
infect
escap
infect
latent
infect
establish
intact
endotheli
cell
harvest
six
day
postinfect
inde
infect
determin
whether
cell
produc
matur
virion
transmiss
electron
microscopi
tem
cell
reveal
virion
variou
stage
matur
throughout
nucleu
cytoplasm
cell
imag
day
postinfect
fig
tem
analysi
fibroblast
hour
postinfect
demonstr
cell
lyse
infect
intact
membran
matur
virion
evid
discern
subcellular
structur
unlik
fibroblast
endotheli
cell
remain
intact
infect
contain
virion
variou
stage
matur
throughout
cytoplasm
nucleu
day
postinfect
cultur
condit
establish
maintain
nonadher
cell
includ
centrifug
resuspens
fresh
media
everi
six
day
fig
test
contribut
nonadher
cell
viru
product
aliquot
supernat
collect
measur
cellfre
viru
cultur
latent
infect
cell
yield
detect
cellfre
viru
six
day
cultur
plaqu
assay
fig
contrast
six
day
cultur
day
postinfect
cellfre
supernat
infect
cell
yield
signific
viral
titer
titer
significantli
higher
supernat
taken
infect
cultur
therefor
endotheli
cell
continu
releas
new
infecti
virion
least
day
postinfect
infect
endotheli
cell
supernat
contain
viru
lyse
infect
fibroblast
cultur
initi
observ
infect
sever
endotheli
cell
line
differ
anatom
locat
result
popul
cell
escap
lysi
focus
analysi
outcom
endotheli
cell
begin
time
collect
day
six
postinfect
count
intact
trypan
blue
exclud
cell
everi
three
day
infect
cell
remain
viabl
least
day
postinfect
fig
cours
infect
number
intact
cell
cultur
increas
sem
sem
first
six
day
cultur
tenfold
increas
correspond
increas
percentag
membran
viabl
cell
also
occur
time
subsequ
day
postinfect
total
number
intact
cell
began
decreas
overal
viabil
cultur
fig
observ
increas
intact
cell
number
percent
viabil
first
six
day
cultur
concurr
posit
stain
fig
fig
indic
endotheli
cell
intact
prolifer
cultur
maintain
lytic
transcript
program
examin
prolifer
observ
first
six
day
cultur
stain
cell
carboxyfluoroscein
cfse
prior
infect
cfse
fluoresc
molecul
use
measur
cell
prolifer
time
cell
divid
two
daughter
cell
contain
half
cfse
parent
cell
cell
demonstr
drop
cfse
signal
intens
six
day
cultur
consist
cell
divis
time
harvest
day
six
postinfect
cell
also
demonstr
drop
cfse
signal
intens
consist
multipl
cell
divis
fig
six
day
cultur
day
postinfect
cfse
signal
intens
drop
consist
continu
cellular
prolifer
thu
endotheli
cell
remain
intact
underw
multipl
round
prolifer
note
day
postinfect
howev
viabil
cultur
quit
low
comparison
earlier
time
point
fig
test
fate
surviv
endotheli
cell
examin
viabil
infect
cell
stain
annexin
v
pi
fig
cell
sem
viabl
annexin
v
neg
pi
neg
two
day
postinfect
sem
viabl
four
day
postinfect
six
day
postinfect
cell
nonadher
sem
nonadher
cell
viabl
contrast
cell
die
cell
domin
infect
cultur
six
day
postinfect
data
indic
mani
cell
die
earli
infect
agreement
prolifer
data
fig
popul
viabl
cell
increas
sem
cultur
day
postinfect
howev
day
postinfect
die
cell
final
domin
infect
cultur
data
support
subset
cell
surviv
prolifer
six
day
postinfect
uniqu
extend
surviv
remain
viabl
indefinit
signific
cours
infect
cell
express
lytic
glycoprotein
surfac
earli
late
time
point
fig
fig
moreov
percentag
cell
express
chang
markedli
time
fig
fig
data
indic
vast
major
viabl
infect
endotheli
cell
undergo
activ
viral
replic
cell
neither
latent
infect
escap
infect
investig
morpholog
differ
uninfect
endotheli
cell
endotheli
cell
harvest
six
day
postinfect
quantifi
cell
size
intern
granular
flow
cytometr
determin
forward
versu
side
scatter
uninfect
cell
exhibit
broad
rang
light
scatter
indic
cell
popul
divers
size
intern
granular
contrast
infect
cell
uniform
forward
side
scatter
fig
paa
treatment
immedi
follow
infect
result
significantli
fewer
cell
becom
nonadher
fig
like
uninfect
cell
cell
treat
paa
follow
infect
exhibit
broad
rang
forward
side
scatter
fig
thu
infect
endotheli
cell
result
uniform
popul
cell
alter
morpholog
outcom
depend
product
viral
infect
late
viral
gene
express
investig
differ
uninfect
endotheli
cell
intact
cell
harvest
six
day
infect
compar
express
cellsurfac
protein
two
cell
popul
flow
cytometri
cell
harvest
six
day
postinfect
persist
cultur
nonadher
cell
chose
investig
surfac
express
adhes
marker
intercellular
adhes
vascular
cell
adhes
addit
analyz
cell
surfac
express
cell
surfac
protein
upregul
surfac
activ
endotheli
cell
function
cellcel
interact
uninfect
cell
express
fig
contrast
infect
endotheli
cell
express
neither
express
base
data
infect
endotheli
cell
downregul
cell
surfac
express
two
adhes
molecul
maintain
surfac
express
activ
marker
demonstr
infect
endotheli
cell
result
popul
intact
cell
persist
cultur
nonadher
cell
continu
produc
new
viru
analysi
endotheli
cell
infect
presenc
paa
indic
outcom
influenc
viral
dna
replic
andor
late
gene
synthesi
fig
fig
begin
dissect
mechan
persist
endotheli
cell
infect
vitro
test
role
viral
cyclin
vcyclin
system
measur
express
vcyclin
infect
endotheli
cell
infect
fibroblast
rtpcr
western
analysi
notabl
vcyclin
gene
transcript
protein
detect
infect
endotheli
cell
fibroblast
fig
fig
determin
role
vcyclin
endotheli
cell
infect
infect
cell
either
wildtyp
vcyclin
defici
vcyclinstop
cell
harvest
six
day
postinfect
cultur
describ
previous
per
previous
publish
report
fibroblast
determin
vcyclin
dispens
growth
endotheli
cell
line
multistep
growth
assay
data
shown
cultur
cell
infect
wildtyp
viru
sem
viabl
day
six
sem
viabl
day
nine
sem
day
sem
day
postinfect
contrast
cultur
cell
infect
vcyclinstop
sem
viabl
day
sem
viabl
day
sem
viabl
day
sem
viabl
day
postinfect
therefor
absenc
vcyclin
endotheli
cell
viabil
significantli
impair
infect
viabil
cell
infect
impair
absenc
vcyclin
next
determin
effect
viral
gene
persist
viral
replic
viabl
endotheli
cell
cell
free
supernat
infect
cell
titer
plaqu
assay
fig
infect
wildtyp
vcyclinstop
viru
result
persist
viral
product
day
postinfect
total
viral
titer
vcyclinstop
infect
significantli
less
wildtyp
infect
day
howev
equival
amount
viru
produc
per
cell
wildtyp
infect
cell
surfac
protein
express
follow
infect
either
wildtyp
vcyclinstop
viru
fig
fig
thu
vcyclin
requir
surfac
phenotyp
infect
endotheli
cell
surfac
phenotyp
infect
endotheli
cell
predict
surviv
therefor
upon
infect
primari
function
vcyclin
promot
viabil
endotheli
cell
given
immort
endotheli
cell
line
inher
differ
endotheli
cell
vivo
next
determin
outcom
infect
primari
endotheli
cell
primari
endotheli
cell
isol
mous
lung
character
per
previous
publish
method
fig
first
determin
primari
lung
endotheli
cell
could
support
growth
wildtyp
multistep
growth
assay
fig
appar
role
vcyclin
infect
endotheli
cell
line
also
analyz
growth
vcyclinstop
viru
primari
endotheli
cell
infect
proceed
kinet
compar
previous
publish
infect
nih
fibroblast
growth
curv
differ
wildtyp
vcyclinstop
viru
data
reveal
primari
endotheli
cell
support
growth
irrespect
vcyclin
second
analyz
percent
cell
remain
viabl
infect
low
moi
immedi
follow
remov
viral
inoculum
mous
embryon
fibroblast
mef
primari
lung
endotheli
cell
differ
significantli
viabil
p
fig
howev
hour
postinfect
wildtyp
primari
lung
endotheli
cell
significantli
viabl
mef
p
remain
significantli
viabl
p
hour
postinfect
p
notabl
endotheli
cell
infect
vcyclin
defici
reduc
viabil
hour
postinfect
given
cell
infect
low
moi
surpris
proport
mef
sem
viabl
hour
postinfect
howev
unlik
endotheli
cell
mef
mostli
lyse
hour
postinfect
wildtyp
viru
data
demonstr
primari
endotheli
cell
surpass
mef
viabil
follow
infect
outcom
promot
vcyclin
lastli
examin
lung
endotheli
cell
follow
acut
infect
vivo
vitro
studi
reveal
viabl
infect
endotheli
cell
latent
infect
uniformli
support
lytic
viral
program
fig
fig
persist
viral
infect
lytic
viral
antigen
express
like
clear
intact
immun
respons
analyz
endotheli
cell
infect
lung
tissu
immunedefici
null
mice
six
day
postintranas
infect
lung
cell
enrich
bear
endotheli
cell
marker
analyz
alongsid
remain
deplet
lung
cell
given
possibl
small
percentag
nonendotheli
cell
transient
express
ie
macrophag
neutrophil
deplet
posit
cell
popul
potenti
contamin
cell
analyz
result
cell
popul
flow
cytometri
fig
pcr
analysi
singl
copi
sensit
rta
perform
determin
frequenc
viral
genom
posit
cell
remain
lung
cell
popul
fig
data
analysi
reveal
approxim
cell
viral
genom
posit
wherea
remain
lung
cell
contain
viral
dna
thu
data
support
surprisingli
larg
proport
lung
endotheli
cell
viral
genom
posit
follow
vivo
infect
demonstr
viral
genom
posit
cell
activ
infect
exclud
possibl
endocyt
uptak
viru
abort
infect
perform
rtpcr
analysi
endotheli
enrich
deplet
lung
cell
fig
transcript
endotheli
cell
marker
robustli
detect
endotheli
enrich
lung
cell
four
mice
analyz
wherea
low
level
transcript
detect
deplet
lung
cell
one
four
mice
analyz
combin
flow
cytometr
analysi
fig
data
support
enrich
strategi
effect
isol
cell
total
lung
cell
addit
viral
pol
transcript
detect
endotheli
cell
enrich
deplet
lung
cell
infect
mice
absent
lung
mock
infect
mice
detect
viral
gene
transcript
lung
cell
indic
viru
infect
cell
notabl
within
infect
mous
pol
detect
compar
endotheli
enrich
lung
cell
popul
suggest
detect
viral
transcript
endotheli
cell
popul
due
contamin
infect
nonendotheli
cell
taken
togeth
data
demonstr
infect
endotheli
cell
vivo
herpesvirus
implic
potenti
initi
varieti
endotheli
patholog
given
intim
interact
observ
herpesvirus
endotheli
cell
system
spread
infect
character
outcom
endotheli
cell
infect
small
anim
model
human
gammaherpesvirus
replic
compar
endotheli
cell
fibroblast
hour
postinfect
infect
cultur
endotheli
cell
high
percentag
viabl
nonadher
cell
remain
follow
infect
signific
viabl
nonadher
cell
simpli
escap
infect
instead
activ
infect
determin
presenc
multipl
marker
lytic
replic
program
absolut
number
viabl
infect
endotheli
cell
vari
among
differ
cell
line
primari
cell
prolong
viabil
endotheli
cell
comparison
fibroblast
remark
consist
endotheli
cell
line
distinct
anatom
locat
well
primari
endotheli
cell
furthermor
optim
surviv
endotheli
cell
line
primari
endotheli
cell
depend
presenc
vcyclin
indic
outcom
process
activ
promot
viru
infect
conserv
outcom
endotheli
cell
infect
particularli
strike
given
endotheli
cell
display
phenotyp
heterogen
structur
function
depend
anatom
locat
base
persist
infect
observ
divers
endotheli
cell
line
heighten
viabil
primari
endotheli
cell
follow
infect
propos
may
evolv
machineri
specif
promot
persist
infect
endotheli
cell
endotheli
cell
serv
natur
site
infect
possibl
viral
reservoir
hcmv
suggest
role
hcmvinfect
endotheli
cell
viral
spread
persist
addit
recent
report
implic
circul
endotheli
progenitor
cell
potenti
reservoir
kshv
possibl
precursor
ks
spindl
cell
howev
specif
mechan
infect
endotheli
cell
contribut
pathogenesi
human
virus
remain
unclear
murin
pathogenesi
involv
dissemin
lung
lymph
node
spleen
peritoneum
light
system
spread
like
encount
endotheli
cell
barrier
human
gammaherpesviru
kshv
caus
seriou
endotheli
cell
malign
ks
predominantli
occur
immunecompromis
individu
eg
aid
patient
ks
tumor
compris
distinct
spindl
cell
endotheli
origin
variabl
inflammatori
infiltr
kshv
detect
primarili
endotheli
compon
lesion
though
cell
harbor
latent
kshv
subset
enter
lytic
cycl
preced
mix
infect
type
within
ks
tumor
ie
lytic
latent
infect
histori
lytic
infect
cell
remain
elus
though
recent
report
point
circul
endotheli
progenitor
cell
vitro
endotheli
cell
infect
kshv
predominantli
latent
howev
cell
transfer
mice
show
evid
lytic
gene
express
viru
product
viral
dna
replic
andor
late
gene
synthesi
import
endotheli
cell
outcom
infect
fig
fig
find
indic
activ
viral
process
occur
within
cell
yield
chang
consist
hypothesi
identifi
vcyclin
requir
optim
endotheli
cell
viabil
infect
vitro
vcyclin
promot
cell
cycl
progress
primari
lymphocyt
function
oncogen
transgen
mice
vcyclin
critic
reactiv
latenc
date
vcyclin
dispens
assay
lytic
replic
vitro
given
lytic
natur
endotheli
cell
infect
contribut
vcyclin
optim
endotheli
cell
viabil
infect
indic
role
vcyclin
outsid
requir
reactiv
latenc
addit
appar
role
vcyclin
prolong
infect
endotheli
cell
line
primari
lung
endotheli
cell
may
explain
slight
decreas
lung
titer
result
mice
infect
low
dose
vcyclinstop
vcyclin
mutant
virus
compar
wildtyp
although
precis
mechan
vcyclin
promot
endotheli
cell
viabil
unknown
time
possibl
vcyclin
provid
growth
cue
allow
anchorageindepend
growth
endotheli
cell
infect
initi
analysi
focus
role
vcyclin
like
addit
viral
gene
facilit
persist
endotheli
cell
infect
lead
candid
includ
antiapoptot
viral
gene
viral
gpcr
orf
whose
homolog
kshv
implic
endotheli
cell
surviv
transform
addit
candid
optim
endotheli
cell
infect
ribonucleotid
reductas
homolog
orf
although
role
gene
infect
endotheli
cell
current
untest
mcmv
ribonucleotid
reductas
homolog
requir
vivo
replic
pathogenesi
endotheli
celltrop
viru
one
notic
alter
persist
infect
endotheli
cell
describ
extent
chang
cellular
morpholog
properti
though
test
oncogen
potenti
cell
endotheli
cell
achiev
anchorageindepend
growth
properti
frequent
associ
oncogen
transform
cell
also
underw
signific
chang
protein
express
cell
surfac
downregul
cellular
adhes
protein
decreas
express
chang
cell
surfac
express
global
sinc
express
remain
posit
cell
fig
worth
note
infect
endotheli
cell
kshv
result
downregul
mhc
class
pecam
fa
viral
gene
demonstr
regul
outcom
contribut
gene
persist
endotheli
cell
infect
remain
untest
downregul
certain
surfac
marker
other
viral
infect
indic
specif
phenomenon
rather
global
downregul
provid
evid
activ
process
respons
observ
endotheli
cell
outcom
infect
may
evolv
mechan
promot
persist
infect
endotheli
cell
eg
vcyclin
also
possibl
endotheli
cell
cellular
program
limit
cellular
lysi
typic
observ
product
infect
put
cellular
adapt
may
particularli
import
limit
destruct
blood
vessel
integr
viral
infect
recent
report
host
cell
respons
three
differ
cell
type
fibroblast
endotheli
precursor
cell
macrophag
identifi
gene
whose
express
alter
endotheli
precursor
cell
macrophag
fibroblast
taken
togeth
uniqu
endotheli
cell
outcom
infect
report
data
make
compel
argument
cell
type
specif
respons
product
infect
provid
evid
infect
endotheli
cell
vivo
earli
time
postinfect
interestingli
infect
cell
includ
endotheli
cell
abund
acut
infect
lung
tissu
littl
gfp
detect
flow
cytometr
analysi
unfraction
lung
cell
infect
gfpmark
viru
data
shown
requir
sensit
pcr
method
detect
vitro
analysi
demonstr
chang
surfac
phenotyp
infect
endotheli
cell
could
correspond
substrat
detach
releas
circul
intrigu
idea
light
publish
report
circul
endotheli
cell
progenitor
endotheli
cell
viru
infect
vitro
studi
implic
endotheli
cell
persist
sourc
viru
product
howev
extent
endotheli
cell
contribut
persist
vivo
degre
might
influenc
host
immun
statu
import
issu
remain
address
unlik
intact
immun
respons
would
permit
longterm
express
viral
antigen
vivo
hypothes
persist
infect
endotheli
cell
could
provid
signific
sourc
continu
viru
replic
immunecompromis
individu
ie
aid
patient
context
gammaherpesvirusassoci
patholog
frequent
occur
given
unusu
properti
viabl
infect
endotheli
cell
eg
anchorageindepend
growth
alter
cell
surfac
protein
express
import
critic
address
potenti
role
endotheli
cell
reservoir
infect
vivo
immunecompet
immunedefici
individu
conclus
data
provid
evid
prolong
gammaherpesviru
infect
endotheli
cell
outcom
appear
result
specif
interact
endotheli
cell
promot
viral
gene
vcyclin
date
uniqu
endotheli
cell
data
refin
concept
gammaherpesviru
infect
demonstr
gammaherpesviru
undergo
robust
product
replic
context
prolong
host
cell
viabil
identif
intermedi
outcom
gammaherpesviru
infect
one
describ
major
implic
understand
natur
gammaherpesviru
infect
relat
specif
cell
type
cours
infect
provid
addit
mechan
beyond
latenc
gammaherpesvirus
achiev
longterm
propag
mous
fibroblast
cell
line
atcc
atcc
mous
endotheli
cell
line
atcc
cultur
dulbecco
modifi
eagl
media
dmem
supplement
fb
hyclon
logan
ut
mm
lglutamin
uml
penicillin
streptomycin
sulfat
tumor
cell
cultur
rpmi
medium
gibco
supplement
fb
mm
sodium
pyruv
mm
lglutamin
uml
penicillin
streptomycin
sulfat
complet
rpmi
mous
embryon
fibroblast
isol
mice
previous
describ
cultur
dmem
supplement
fb
mm
lglutamin
uml
penicillin
streptomycin
ngml
fungizon
isol
character
cultur
primari
endotheli
cell
mice
done
accord
previous
publish
method
describ
protocol
text
figur
wum
atcc
recombin
virus
grown
titer
previous
describ
contain
gfp
cassett
control
immedi
earli
cmv
promot
gener
character
dr
phillip
stevenson
contain
stop
codon
within
orf
vcyclinstop
previous
describ
infect
carri
multipl
infect
moi
plaqu
form
unit
pfu
per
cell
inoculum
remov
one
hour
infect
cell
monolay
rins
three
time
steril
phosphat
buffer
salin
pb
complet
media
ad
intact
nonadher
cell
collect
six
day
postinfect
time
cell
media
collect
count
determin
postinfect
viabil
trypan
blue
exclus
centrifug
minut
cell
pellet
wash
twice
steril
pb
resuspend
complet
rpmi
concentr
viabl
cellsml
continu
cultur
cell
count
everi
three
day
cultur
adjust
concentr
viabl
cellsml
everi
six
day
cultur
cell
count
centrifug
minut
remov
cellfre
cellular
debri
pellet
wash
twice
steril
pb
resuspend
rpmi
concentr
viabl
cellsml
cultur
scheme
depict
supplement
fig
measur
viru
replic
infect
sampl
analyz
plaqu
assay
variou
time
postinfect
measur
cellfre
viru
titer
infect
cultur
supernat
collect
everi
six
day
cultur
analyz
plaqu
assay
sampl
thaw
serial
dilut
plate
onto
nih
cell
well
plate
triplic
infect
perform
one
hour
cell
overlaid
mix
dmem
carboxymethylcellulos
plu
fungizon
final
concentr
ngml
plate
incub
seven
day
day
seven
carboxymethylcellulos
remov
plate
stain
methylen
blue
methanol
rotat
minut
rins
water
count
light
box
titer
determin
parallel
laboratori
standard
propidium
iodin
pi
viabil
studi
cell
wash
twice
pb
five
minut
resuspend
pi
solut
incub
minut
follow
incub
cell
centrifug
five
minut
wash
solut
pb
fetal
calf
serum
buffer
cell
fix
paraformaldehyd
analyz
flow
cytometri
two
paramet
viabil
analysi
cell
wash
annexin
v
bind
buffer
bd
bioscienc
san
jose
ca
resuspend
pi
annexin
vfitc
bd
bioscienc
incub
minut
wash
bind
buffer
fix
paraformaldehyd
analyz
flow
cytometri
carboxyfluorescein
cfse
prolifer
studi
cell
sll
cell
wash
twice
pb
five
minut
resuspend
solut
pb
fetal
calf
serum
buffer
b
concentr
cell
per
ml
equal
volum
cfse
buffer
b
ad
cell
suspens
final
concentr
pipet
mix
three
minut
label
reaction
quench
equal
volum
fetal
calf
serum
second
buffer
b
ad
total
volum
ml
cell
centrifug
five
minut
resuspend
buffer
b
aliquot
collect
day
analysi
remain
label
cell
resuspend
complet
media
cultur
label
cell
infect
moi
pfucel
infect
cell
harvest
describ
day
six
postinfect
analyz
flow
cytometri
six
day
postinfect
stain
unstain
cell
analyz
time
posit
control
surfac
marker
stain
cell
wash
twice
buffer
five
minut
resuspend
primari
antibodi
buffer
follow
primari
antibodi
use
rat
clone
mvcama
armenian
hamster
clone
rat
clone
bd
bioscienc
monoclon
mous
mous
kind
gift
dr
phillip
stevenson
cell
incub
minut
room
temperatur
follow
incub
cell
centrifug
twice
buffer
five
minut
resuspend
either
buffer
secondari
stain
reagent
buffer
incub
minut
room
temperatur
secondari
stain
reagent
either
streptavidinapc
bd
bioscienc
antimous
rat
clone
bd
bioscienc
cell
centrifug
twice
buffer
five
minut
analyz
flow
cytometri
forward
versu
side
scatter
analysi
cell
harvest
six
day
postinfect
analyz
uninfect
cell
detach
flask
mm
edta
analyz
parallel
infect
cell
certain
experi
determin
effect
viral
dna
replic
andor
late
gene
synthesi
forward
side
scatter
properti
cell
treat
phosphonoacet
acid
paa
one
hour
infect
six
day
postinfect
nonadher
cell
harvest
count
trypan
blue
exclus
determin
percent
cell
infect
viabl
nonadher
time
harvest
cell
remain
adher
flask
detach
mm
edta
combin
harvest
nonadher
cell
analyz
flow
cytometri
forward
side
scatter
properti
effect
block
late
gene
synthesi
confirm
plaqu
assay
titer
treat
cell
viral
titer
reduc
hour
six
day
compar
untreat
cell
micron
control
bead
run
parallel
experi
beckman
coulter
fullerton
ca
cell
collect
boil
laemmli
buffer
minut
total
protein
concentr
cell
extract
determin
lowri
assay
dc
protein
assay
kit
biorad
hercul
ca
total
protein
per
extract
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
protein
electrotransf
thermofish
scientif
portsmouth
nh
pvdf
membran
millipor
billerica
block
pb
nonfat
milk
one
hour
room
temperatur
western
blot
protein
express
incub
monoclon
mous
gb
kind
gift
dr
phillip
stevenson
monoclon
mous
polyclon
rabbit
vcyclin
kind
gift
dr
herbert
virgin
monoclon
antibodi
mous
sigma
chemic
st
loui
mo
blot
wash
minut
pb
incub
donkey
antimous
donkey
antirabbit
antibodi
one
hour
blot
wash
pb
contain
minut
protein
visual
use
ecl
plu
western
blot
detect
kit
amersham
pharmacia
biotech
total
rna
extract
cell
infect
nih
cell
infect
cell
murin
lung
cell
fraction
use
mirna
isol
kit
ambion
austin
tx
per
manufactur
instruct
amplif
conduct
use
follow
primer
set
forward
caa
cag
gtc
acc
gat
cc
revers
gga
agt
acg
gcc
att
tc
forward
taa
gga
cct
cgt
aga
gat
tgg
c
revers
acg
tta
aag
tcc
cca
tgg
aag
c
vcyclin
forward
att
agc
act
ggg
cgt
ttc
atg
vcyclin
revers
gac
ctc
cgt
cag
gat
aac
aac
mous
forward
gcc
acc
agt
tcg
cca
tgg
mous
revers
caa
tgc
cat
gtt
caa
tgg
ggt
mous
forward
aga
tca
aaa
cca
acc
cgg
tga
mous
revers
ggt
aag
agc
atc
gag
ggg
gc
mous
cyclophilin
forward
att
tgg
cta
taa
ggg
ttc
ctc
mous
cyclophilin
revers
acg
ctc
cat
ggc
ttc
cac
aat
mous
forward
agg
gga
cca
gct
gca
cat
tag
g
mous
revers
agg
ccg
ctt
ctc
ttg
acc
act
rtpcr
reaction
carri
use
onestep
rtpcr
kit
qiagen
valencia
ca
contain
final
concentr
primer
ng
rna
treat
rnasefre
dnase
promega
madison
wi
prior
addit
rtpcr
reaction
mix
rtpcr
reaction
perform
follow
min
revers
transcript
min
heat
inactiv
revers
transcriptas
activ
taq
polymeras
amplif
cycl
sec
follow
second
depend
tm
primer
set
follow
one
min
singl
incub
minut
templat
rt
control
includ
pcr
neg
cell
pellet
five
minut
resuspend
ml
pb
pellet
five
minut
supernat
remov
glutaraldahyd
solut
adjust
ph
use
hcl
mosm
use
ad
sampl
process
imag
dr
gari
mierau
children
hospit
depart
pathologylaboratori
servic
aurora
co
briefli
sampl
postfix
cacodyl
buffer
osmium
tetroxid
ph
dehydr
grade
seri
alcohol
embed
epoxi
resin
section
approxim
nm
thick
stain
uranyl
acet
lead
citrat
prior
examin
kv
zeiss
transmiss
electron
microscop
carl
zeiss
inc
thornwood
ny
lung
tissu
remov
knockout
mice
six
day
postintranas
inocul
pfu
tissu
enzymat
digest
endotheli
cell
purifi
use
endotheli
cell
marker
fig
briefli
cell
stain
follow
antibodi
clone
mec
rat
bd
bioscienc
clone
rat
bd
bioscienc
clone
rat
ebiosci
san
diego
ca
clone
rat
ebiosci
clone
rat
bd
bioscienc
clone
rat
bd
bioscienc
cell
magnet
label
antibiotin
multisort
bead
separ
octomac
separ
unit
releas
multisort
bead
per
manufactur
instruct
miltenyi
biotec
inc
auburn
ca
releas
cell
incub
antip
multisort
bead
deplet
contamin
pe
posit
cell
magnet
separ
flow
cytometr
analysi
perform
confirm
flow
fraction
pe
column
enrich
posit
cell
deplet
pe
posit
cell
fig
frequenc
lung
cell
knockout
mice
contain
genom
determin
use
previous
describ
nest
pcr
assay
ldpcr
singlecopi
sensit
detect
gene
briefli
freshli
isol
cell
count
resupsend
isoton
solut
dilut
uninfect
nih
cell
prior
serial
dilut
plate
plate
cell
lyse
overnight
proteinas
k
follow
two
round
nest
pcr
reaction
perform
replic
per
dilut
per
sampl
product
resolv
agaros
gel
identifi
ethidium
bromid
stain
pcr
sensit
quantit
use
copi
gene
contain
plasmid
pbamh
n
dilut
uninfect
nih
cell
data
analyz
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
data
analyz
use
pair
student
test
determin
statist
signific
limit
dilut
data
subject
nonlinear
regress
analysi
frequenc
genomeposit
cell
calcul
use
poisson
distribut
assum
cell
number
event
detect
correspond
occurr
singl
event
cypa
wum
complet
genom
vcyclin
gb
